Literature DB >> 22583022

Genetic and functional analysis of HIV type 1 nef gene derived from long-term nonprogressor children: association of attenuated variants with slow progression to pediatric AIDS.

Guillermo Corró1, Carlos A Rocco, Cristian De Candia, Gabriel Catano, Gabriela Turk, Andrea Mangano, Paula C Aulicino, Rosa Bologna, Luisa Sen.   

Abstract

Among persons infected by HIV-1, the rate of progression to AIDS is multifactorial being affected by host and viral factors, including the HIV-encoded negative factor (Nef). Our aim was to define whether variations in the nef gene as well as its functions may be associated with slower HIV disease course in infected children. The proviral HIV-1 nef gene was cloned, sequenced, and compared in children with contrasting disease course: 10 long-term nonprogressors (LTNP) and six rapid progressor (RP). The CD4 and MHC-I down-modulation ability of nef alleles derived from LTNP and RP children was analyzed. We observed that only one of our 10 LTNP had a protective genetic background, and out of them, 40% had defective nef genes, carrying substitutions at the (AWLEAQ(56-61)) and the (Rxx(22-24)) domains, and that those alleles were unable of down-regulate CD4 and MHC-I. The emergence or presence of Nef L58V substitution was associated with viral attenuation, indicated by a reduction in HIV viral loads, a persistent preservation of CD4(+) T cell counts, and lack of AIDS-related symptoms. Our results demonstrate that HIV-1 perinatally infected children carrying functionally defective nef HIV-1 strains have prolonged asymptomatic phases without therapy, suggesting a relevant role of CD4 and MHC-I down-modulation Nef domains on in vivo HIV-1 pathogenesis and pediatric immunodeficiency outcome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22583022     DOI: 10.1089/AID.2012.0020

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

1.  Cognition, Emotional Health, and Immunological Markers in Children With Long-Term Nonprogressive HIV.

Authors:  Robert Paul; Tanakorn Apornpong; Wasana Prasitsuebsai; Thanyawee Puthanakit; Vonthanak Saphonn; Linda Aurpibul; Pope Kosalaraksa; Suparat Kanjanavanit; Wicharn Luesomboon; Chaiwat Ngampiyaskul; Tulathip Suwanlerk; Kea Chettra; William T Shearer; Victor Valcour; Jintanat Ananworanich; Stephen Kerr
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

2.  Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes.

Authors:  Lisa Naidoo; Zinhle Mzobe; Steven W Jin; Erasha Rajkoomar; Tarylee Reddy; Mark A Brockman; Zabrina L Brumme; Thumbi Ndung'u; Jaclyn K Mann
Journal:  Virology       Date:  2019-02-21       Impact factor: 3.616

3.  No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.

Authors:  Denis R Chopera; Jaclyn K Mann; Philip Mwimanzi; Saleha Omarjee; Xiaomei T Kuang; Nonkululeko Ndabambi; Sarah Goodier; Eric Martin; Vivek Naranbhai; Salim Abdool Karim; Quarraisha Abdool Karim; Zabrina L Brumme; Thumbi Ndung'u; Carolyn Williamson; Mark A Brockman
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

Review 4.  Viral factors in non-progression.

Authors:  Bin Wang
Journal:  Front Immunol       Date:  2013-12-24       Impact factor: 7.561

5.  High levels of anti-Nef antibodies may prevent AIDS disease progression in vertically HIV-1-infected infants.

Authors:  Guillermo Corró; Cintia Milena Crudeli; Carlos Alberto Rocco; Silvia Alejandra Marino; Luisa Sen
Journal:  J Int AIDS Soc       Date:  2014-02-14       Impact factor: 5.396

6.  Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case study.

Authors:  Hanwei Sudderuddin; Natalie N Kinloch; Steven W Jin; Rachel L Miller; Bradley R Jones; Chanson J Brumme; Jeffrey B Joy; Mark A Brockman; Zabrina L Brumme
Journal:  Retrovirology       Date:  2020-01-09       Impact factor: 4.602

Review 7.  Human leukocyte antigen (HLA) class I down-regulation by human immunodeficiency virus type 1 negative factor (HIV-1 Nef): what might we learn from natural sequence variants?

Authors:  Philip Mwimanzi; Tristan J Markle; Takamasa Ueno; Mark A Brockman
Journal:  Viruses       Date:  2012-09-24       Impact factor: 5.048

8.  Attenuation of multiple Nef functions in HIV-1 elite controllers.

Authors:  Philip Mwimanzi; Tristan J Markle; Eric Martin; Yoko Ogata; Xiaomei T Kuang; Michiyo Tokunaga; Macdonald Mahiti; Florencia Pereyra; Toshiyuki Miura; Bruce D Walker; Zabrina L Brumme; Mark A Brockman; Takamasa Ueno
Journal:  Retrovirology       Date:  2013-01-07       Impact factor: 4.602

9.  Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.

Authors:  Jaclyn K Mann; Helen Byakwaga; Xiaomei T Kuang; Anh Q Le; Chanson J Brumme; Philip Mwimanzi; Saleha Omarjee; Eric Martin; Guinevere Q Lee; Bemuluyigza Baraki; Ryan Danroth; Rosemary McCloskey; Conrad Muzoora; David R Bangsberg; Peter W Hunt; Philip J R Goulder; Bruce D Walker; P Richard Harrigan; Jeff N Martin; Thumbi Ndung'u; Mark A Brockman; Zabrina L Brumme
Journal:  Retrovirology       Date:  2013-09-16       Impact factor: 4.602

10.  Pediatric HIV Long-Term Nonprogressors.

Authors:  B H Rimawi; R H Rimawi; M Micallef; L Pinckney; S L Fowler; T C Dixon
Journal:  Case Rep Infect Dis       Date:  2014-08-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.